NCT06159777View on ClinicalTrials.gov

Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
ConstipationSurgical Procedure, UnspecifiedProlapse; Female
Interventions
DRUG

Polyethylene Glycol 3350

\*Polyethylene glycol 3350 (PEG) will be used within it's FDA indication and dosing for constipation. Each 17-gram dose of PEG is to be mixed in 8oz of liquid.

Trial Locations (1)

44106

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER